Hoitt Jason's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed Mar 19, 2026
- Accession no.
- 0001762572-26-000006
- Filed
- Mar 19, 2026
- Trade date
- Mar 17-18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $119.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoitt JasonCIK 0001762572 | Officer (Chief Patient Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock | SSaleDisposed | −1,033 | $32.74 | −$33,820.42 | 12,955 | Direct | |
| Mar 17, 2026 | Common Stock | SSaleDisposed | −748 | $33.38 | −$24,968.24 | 12,207 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −1,762 | $31.28 | −$55,115.36 | 10,445 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −139 | $31.79 | −$4,418.81 | 10,306 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −30 | $32.85 | −$985.5 | 10,276 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.